The Europe Dialyzer Market would witness market growth of 5.80% CAGR during the forecast period (2019-2025). A kidney?s function is to remove any waste products and excess fluids from the bloodstream. When the kidneys do not function normally, a dialyzer does the work. Therefore, a dialyzer can also be called as an artificial kidney. Waste products like urea and creatinine are taken out from the blood through artificial and natural semipermeable membranes. An increasing number of ESRD patients, a higher incidence of diabetes and hypertension, and a surge in the funding for improved dialysis products and services are influencing the growth of the dialyzer market. Moreover, due to the absence of matching donors, dialysis is preferred over kidney transplant, which is anticipated to further boost the market. However, dialysis-related hazards and complications and product reuse are anticipated to hamper market progression.
Based on Type, the market is segmented into High-Flux Dialyzer and Low-Flux Dialyzer. Based on End User, the market is segmented into In-Center Dialysis and Home Dialysis. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., CVS Health Corporation, Fresenius Medical Care AG & Co. KGaA, DaVita, Inc., Asahi Kasei Corporation, Cardinal Health, Inc., Cantel Medical Corporation, Nipro Corporation, Allmed Medical Care Holdings Limited and Terumo Corporation.
Market Segmentation:
By Type
By End User
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
